All Stories

  1. Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management
  2. Inflammatory Bowel Disease Therapies Adversely Affect Fertility in Men- A Systematic Review and Meta-analysis
  3. Interferon-Gamma and Tumor Necrosis Factor-Related Weak Inducer of Apoptosis Expression in Neoangiogenesis in Colorectal Polypoid Lesions
  4. Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery
  5. PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
  6. Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis
  7. Diffusion-weighted magnetic resonance for assessing fibrosis in Crohn’s disease
  8. CD80 expression promotes immune surveillance in Barrett’s metaplasia
  9. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis
  10. Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis
  11. Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases
  12. Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells
  13. S quamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity
  14. A Case of Carcinosarcoma of the Gastroesophageal Junction With Neuroendocrine and Chondroid Differentiation
  15. Psychological support of esophageal cancer patient?
  16. Human papillomavirus infection is not involved in esophageal verrucous carcinoma
  17. Electrochemotherapy – Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration
  18. miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis
  19. Cholecystectomy during esophagectomy is safe but unnecessary
  20. Herpes Simplex Virus Type 1 Engages Toll Like Receptor 2 to Recruit Macrophages During Infection of Enteric Neurons
  21. Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
  22. Esophageal cancer patients’ information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information
  23. Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
  24. Antibacterial efficacy and mechanisms of action of low power atmospheric pressure cold plasma: membrane permeability, biofilm penetration and antimicrobial sensitization
  25. Time to diagnosis in esophageal cancer: a cohort study
  26. Herpes Simplex Virus Type 1 Infects Enteric Neurons and Triggers Gut Dysfunction via Macrophage Recruitment
  27. Long-term quality of life after esophagectomy with gastric pull-up
  28. Potential curability and perception of received information in esophageal cancer patients
  29. Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance
  30. Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms
  31. A systematic review of segmental vs subtotal colectomy and subtotal colectomy vs total proctocolectomy for colonic Crohn's disease
  32. Colorectal cancer in the young: a possible role for immune surveillance?
  33. Randomized clinical trial of psychological support and sleep adjuvant measures for postoperative sleep disturbance in patients undergoing oesophagectomy
  34. Hedgehog signaling in colorectal cancer: a spiny issue gets smoothened
  35. CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis
  36. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC
  37. Impact of esophagectomy for cancer on patients' occupational status
  38. The Role of Surgery in Patients With a Complete Clinical Response After Chemoradiation for Esophageal Cancer
  39. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance
  40. Hybrid minimally invasive esophagectomy for cancer: impact on postoperative inflammatory and nutritional status
  41. Health related quality of life after oesophagectomy: elderly patients refer similar eating and swallowing difficulties than younger patients
  42. TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn's disease
  43. Postoperative outcome after oesophagectomy for cancer: Nutritional status is the missing ring in the current prognostic scores
  44. Esophagectomy in elderly patients: which is the best prognostic score?
  45. Systematic review of surgical treatment of subclinical Cushing's syndrome
  46. Palliative therapy for esophageal cancer: laser therapy alone is associated with a better functional outcome
  47. Intestinal Surgery for Crohn's Disease: Role of Preoperative Therapy in Postoperative Outcome
  48. The effects of acupuncture after thyroid surgery: A randomized, controlled trial
  49. Complications after surgery for colorectal cancer affect quality of life and surgeon-patient relationship
  50. Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study
  51. Oesophageal cancer: assessment of tumour response to chemoradiotherapy with tridimensional CT
  52. Esophageal Cancer Management: Preoperative CA19.9 and CEA Serum Levels May Identify Occult Advanced Adenocarcinoma
  53. Diffusion-Weighted Magnetic Resonance for Assessing Ileal Crohnʼs Disease Activity
  54. MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma
  55. Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution
  56. Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis
  57. Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis
  58. Sleep disturbances and quality of life in postoperative management after esophagectomy for esophageal cancer
  59. Minimally invasive treatment of peristomal metastases from gastric cancer at an ileostomy site by electrochemotherapy
  60. Minimally invasive surgery for esophageal cancer: a review on sentinel node concept
  61. Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?
  62. The Effect of Dichotomizing Age in Outcomes Assessment of the Surgical Management of Esophageal Cancer
  63. Minimally invasive surgery for colorectal cancer: quality of life and satisfaction with care in elderly patients
  64. More information about the pattern of lymphatic spread could improve the effectiveness of surgery for esophageal cancer
  65. Low Perioperative Serum Prealbumin Predicts Early Recurrence After Curative Pulmonary Resection for Non-Small-Cell Lung Cancer
  66. Health-Related Quality of Life in Patients with Oesophageal Cancer: Analysis at Different Steps of the Treatment Pathway
  67. Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4–NFκB signalling
  68. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis
  69. What is the optimal management of dysphagia in metastatic esophageal cancer?
  70. Does Obesity Affect Outcomes in Patients Undergoing Esophagectomy for Cancer? Comments on a Meta-analysis
  71. Overweight Patients Operated on for Cancer of the Esophagus Survive Longer than Normal-Weight Patients
  72. Intraoperative Blood Transfusion Contributes to Decreased Long-Term Survival of Patients with Esophageal Cancer: Comments on Regression Model Estimation
  73. Innate Immune Environment in Ileal Pouch Mucosa: α5 Defensin Up-regulation as Predictor of Chronic/Relapsing Pouchitis
  74. TLR2 and TLR4 Up-regulation and Colonization of the Ileal Mucosa by Clostridiaceae spp. in Chronic/Relapsing Pouchitis
  75. Magnetic Resonance Enterography for Crohn’s Disease: What the Surgeon Can Take Home
  76. Relationship between mucosa-associated microbiota and inflammatory parameters in the ileal pouch after restorative proctocolectomy for ulcerative colitis
  77. Nodal Metastasis From Locally Advanced Esophageal Cancer: How Neoadjuvant Therapy Modifies Their Frequency and Distribution
  78. Mucosal immune environment in colonic carcinogenesis: CD80 up-regulation in colonic dysplasia in ulcerative colitis
  79. Long-term health-related quality of life after minimally invasive surgery for diverticular disease
  80. Systematic review of health-related quality of life after esophagectomy for esophageal cancer
  81. Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis
  82. Perianal Crohn’s disease: Is there something new?
  83. Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia
  84. A systematic review on advancement flaps for rectovaginal fistula in Crohn’s disease: transrectal vs transvaginal approach
  85. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
  86. Diode laser treatment of Barrett’s esophagus: long-term results
  87. A systematic review of diagnostic procedures to detect midgut neuroendocrine tumors
  88. Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis
  89. Clinical Presentation and Diagnosis of Intestinal Adenocarcinoma in Crohn’s Disease: Analysis of Clinical Predictors and of the Life-Time Risk
  90. Ileal neuroendocrine carcinoma following restorative proctocolectomy for colonic adenocarcinoma in Crohn's disease
  91. Deep Venous Thrombosis After Surgery for Inflammatory Bowel Disease: Is Standard Dose Low Molecular Weight Heparin Prophylaxis Enough?
  92. Quality of life after surgery of the alimentary tract
  93. Health related quality of life after surgery for colonic diverticular disease
  94. Subclinical Intestinal Inflammation in Patients with Crohn’s Disease Following Bowel Resection: A Smoldering Fire
  95. Intestinal Surgery for Crohn’s Disease: Predictors of Recovery, Quality of Life, and Costs
  96. The hostile neck does not increase the risk of carotid endarterectomy
  97. Reduced Endothelial Progenitor Cell Number and Function in Inflammatory Bowel Disease: A Possible Link to the Pathogenesis
  98. Restorative proctocolectomy for inflammatory bowel disease
  99. Diverting loop ileostomy after restorative proctocolectomy: predictors of poor outcome and poor quality of life
  100. TGF-β1 and IGF-1 Production and Recurrence of Crohn's Disease After Ileo-Colonic Resection
  101. Plasma lipids and inflammation in active inflammatory bowel diseases
  102. Inflammatory Fibroid Polyp Causing Intestinal Obstruction following Restorative Proctocolectomy for Ulcerative Colitis
  103. Validation of an English Version of the Padova Quality of Life Instrument to Assess Quality of Life Following Ileal Pouch Anal Anastomosis
  104. Cytokine network in rectal mucosa in perianal Crohnʼs disease: Relations with inflammatory parameters and need for surgery
  105. A systematic review on the clinical diagnosis of gastrointestinal stromal tumors
  106. Health-Related Quality of Life after Colonic Resection for Diverticular Disease: Long-term Results
  107. TGF-β1 and IGF-1 and Anastomotic Recurrence of Crohn’s Disease After Ileo-Colonic Resection
  108. Double contrast small-bowel radiography in the preoperative assessment of Crohn’s disease: Is it still useful?
  109. Lipid and phospholipid profile after bowel resection for Crohn’s disease
  110. Minimally invasive surgery for colorectal cancer: quality of life, body image, cosmesis, and functional results
  111. Gastrointestinal telangiectasia: a study by EGD, colonoscopy, and capsule endoscopy in 75 patients
  112. Endoscopic Dilation of Benign Esophageal Strictures in a Surgical Unit
  113. Restorative Proctocolectomy for Ulcerative Colitis: Impact on Lipid Metabolism and Adipose Tissue and Serum Fatty Acids
  114. Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohnʼs Disease
  115. Surgical predictors of recurrence of Crohn’s disease after ileocolonic resection
  116. Enzymes in feces: Useful markers of chronic inflammatory bowel disease
  117. Health-Related Quality of Life after Ileocolonic Resection for Crohnʼs Disease: Long-term Results
  118. B1a lymphocytes in ulcerative colitis
  119. Adenocarcinoma after restorative proctocolectomy for cancer in ulcerative colitis
  120. Quality of Life After Restorative Proctocolectomy for Ulcerative Colitis
  121. Cytokine Network in Chronic Perianal Crohn’s Disease and Indeterminate Colitis After Colectomy
  122. Decision making for metastatic diseases to the ovaries from colorectal cancer
  123. Ovarian metastasis from colorectal cancer: Prognostic value of radical oophorectomy
  124. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis
  125. Rod in loop ileostomy: just an insignificant detail for ileostomy-related complications?
  126. Expression of costimulatory molecule CD80 in colonic dysplasia in ulcerative colitis: an immunosurveillance mechanism against colorectal cancer?
  127. Are frozen sections useful and cost-effective in the era of intraoperative qPTH assays?
  128. A Gastrocolic Fistula in Crohn’s Disease
  129. Ileostomy for constipation: long-term postoperative outcome
  130. Unusual cause of small bowel perforation: metastasis of a subcutaneous angiosarcoma of the head
  131. Early Surgery for the Treatment of Toxic Megacolon
  132. The Role of Costimulatory Molecules CD80 and CD86 and IFNγ in the Pathogenesis of Ulcerative Colitis
  133. Health-related quality of life after restorative proctocolectomy for ulcerative colitis: Long-term results
  134. The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation
  135. Life table analysis of hernia following end colostomy construction